Finally, given the absence of information regarding molecular subtypes within the UKBB cohort, the selection of GBM cases based on isocitrate dehydrogenase-wildtype as reported by the most recent WHO classification of CNS tumours (5th edition, 2021) was not possible because of the lack of this information in UKBB. Here, IDH3A is linked to central nervous system neoplasm.